ICL Group reported $7.15 billion in annual sales for fiscal year 2025, with a 6% year-over-year increase in fourth-quarter revenue, driven by robust demand for specialty chemicals and agricultural inputs. The results reinforce the company’s position in industrial and agronomic markets.
- ICL Group reported $7.15 billion in annual sales for 2025
- Fourth-quarter sales rose 6% year-over-year
- Strong demand for agricultural nutrients and specialty chemicals
- Adjusted EBITDA margins held near 30%
- Expansion in lithium hydroxide production underway
- Positive market reaction with stock and related commodity gains
ICL Group delivered $7.15 billion in total annual sales for 2025, reflecting a solid performance across its core operations in specialty chemicals and agricultural nutrients. The fourth quarter marked a 6% increase in sales compared to the same period in 2024, supported by sustained global demand for crop nutrition solutions and industrial materials. The company’s growth trajectory underscores strong market positioning in key regions, particularly in North America and Europe, where demand for high-efficiency fertilizers and mineral-based additives remained elevated. ICL’s diversified portfolio—including potash, phosphates, and specialty lithium compounds—continued to benefit from supply constraints in alternative inputs and increased investment in precision agriculture. Financial metrics highlight operational efficiency, with adjusted EBITDA margins holding steady near 30%, indicating cost discipline amid volatile raw material pricing. The company also reinvested in capacity expansion projects, including a new lithium hydroxide production line in Israel, signaling long-term strategic growth ambitions. Market participants responded positively, with ICL’s stock showing a modest 2.3% uptick in after-hours trading. Related commodity markets, including potash (CL=F) and soybean futures (SOY=F), also saw marginal gains, suggesting broader investor confidence in agricultural input cycles.